Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-014096
Filing Date
2017-07-26
Accepted
2017-07-26 17:29:20
Documents
45
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mnov-10q_20170630.htm 10-Q 712791
2 EX-10.1 mnov-ex101_306.htm EX-10.1 191091
3 EX-31.1 mnov-ex311_7.htm EX-31.1 10995
4 EX-31.2 mnov-ex312_9.htm EX-31.2 10900
5 EX-32.1 mnov-ex321_8.htm EX-32.1 7873
6 EX-32.2 mnov-ex322_6.htm EX-32.2 7802
  Complete submission text file 0001564590-17-014096.txt   2588369

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mnov-20170630.xml EX-101.INS 325763
8 XBRL TAXONOMY EXTENSION SCHEMA mnov-20170630.xsd EX-101.SCH 24650
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20170630_cal.xml EX-101.CAL 23106
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20170630_def.xml EX-101.DEF 77957
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20170630_lab.xml EX-101.LAB 204423
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20170630_pre.xml EX-101.PRE 155810
Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 17983809
SIC: 2834 Pharmaceutical Preparations